Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001069530-19-000070
Filing Date
2019-12-26
Accepted
2019-12-26 16:00:21
Documents
1
Period of Report
2019-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4a.html 4/A  
1 PRIMARY DOCUMENT certent-form4a.xml 4/A 3747
  Complete submission text file 0001069530-19-000070.txt   5123
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BARBIER REMI (Reporting) CIK: 0001133806 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-29959 | Film No.: 191310576